Louisiana lawsuit claims man’s mesothelioma diagnosis linked to workplace asbestos exposure

27 Jul 2016 by under Legal

asbestos warning Louisiana lawsuit claims mans mesothelioma diagnosis linked to workplace asbestos exposureBeing exposed to a toxic substance while on the job is a familiar reality for many unsuspecting workers; however, it isn’t until someone is diagnosed with a deadly condition when it is revealed they’ve been working in an unsafe environment.

Gistarve Joseph Sr. has now filed suit against Huntington Ingalls Industries, American Motorists Insurance Co., American Employer’s Insurance Co., OneBeacon America Insurance Co., et al., upon learning he developed following years of exposure. The lawsuit was filed in Louisiana’s Orleans Parish District Court on June 8.

Diseases caused by asbestos exposure tend to have a long latency period of between 20 and 40 years, causing a delay between the actual exposure and diagnosis. The most notorious of these diseases is mesothelioma – an aggressive form of cancer affecting the lining of the lungs or abdomen caused almost solely by asbestos exposure. Asbestosis, another asbestos-related disease, occurs when lung tissue is scarred by asbestos fibers. Both diseases currently are without a cure, leaving victims like Joseph without many options.

Joseph’s lawsuit claims that he was exposed to asbestos regularly while working as a shipfitter for Avondale Industries. According to his claim, it wasn’t until April 26 of this year when he was finally diagnosed with mesothelioma. The lawsuit continues to state that the defendants listed above are responsible for his diagnosis due to their negligence by failing to make the plaintiff aware of the dangers present in his workplace, failing to provide a safe workplace, as well as failure to prevent such incidents from occurring in the first place.

Joseph is now seeking an unspecified amount in damages from the defendants and has been assigned to Division C Judge Sidney H. Cates IV, Chief Judge.

Source: Louisiana Record


Comments are closed.